Human MIP-1 alpha ELISA Kit
search
  • Human MIP-1 alpha ELISA Kit

Human MIP-1 alpha ELISA Kit

Catalog # FM-E100091

Print

$649.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

31.2 - 2,000 pg/mL  

Sensitivity

10.0 pg/mL

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Human MIP-1 alpha standard: 2 vials

 2. One 96-well plate coated with Human MIP-1 alpha  Ab

 3. Sample diluent buffer: 12 ml— 2

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

 9. Stop solution: 10 mL x1

10. Washing solution (20x): 25 mL x1

 

 

Background

 

Macrophage Inflammatory Protein-1 alpha (MIP-1α), also known as CCL3, G0/G1 switch regulatory protein 19-1, PAT 464.1, SIS-beta, small-inducible cytokine A3, Tonsillar lymphocyte LD78 alpha protein, is a member of the CC family. Human MIP-1α is synthesized as a 92 amino acid (aa) precursor protein consisting of a 22 aa residue signal peptide and a 70aa secreted mature protein. MIP-1α is expressed on various cell types such as activated T cells, B cells, monocytes, mast cells, neutrophils, Langerhans cells, astrocytes, endothelial cells, fibroblasts and smooth muscle cells.

MIP-1α is a ligand for CCR1, CCR4 and CCR5. Primarily, MIP-1α plays a chemotractic role in diverse immune cells including monocyte, T-lymphocytes, NK cells, cytotoxic T cells, B cells, basophils, and eosinophils. In addition, MIP-1α can function as a stem cell inhibitor (SCI) to inhibit the proliferation of hematopoietic progenitor cells both in vitro and in vivo.

New